Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 107
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04240210 | Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) | ||
| NCT02207062 | Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma | ||
| NCT02422797 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2) | ||
| NCT05629052 | TrEatment Approach in the Multimodal Era Registry | ||
| NCT04116606 | Antidepressant Trial With P2X7 Antagonist JNJ-54175446 | ||
| NCT02841033 | Daratumumab for the Treatment of Patients With AL Amyloidosis | ||
| NCT02002130 | The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes | ||
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | ||
| NCT00959894 | Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection | ||
| NCT03236428 | Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma | ||
| NCT06549634 | Biomarkers of AKI in Patients Receiving Daratumumab | ||
| NCT00002132 | Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. | ||
| NCT02249923 | Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry | ||
| NCT06066346 | A Study of Talquetamab for People with Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy | ||
| NCT05304858 | Tumor Microenvironment Analysis of Prostate Cancer Metastasis | ||
| NCT03899155 | Pan Tumor Rollover Study | ||
| NCT05117931 | A Study of Amivantamab in People With Esophagogastric Cancer | ||
| NCT02955810 | Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) | ||
| NCT05109559 | Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine | ||
| NCT06232551 | Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism | ||
| NCT02342249 | Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects | ||
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT03404635 | Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism | ||
| NCT05896748 | Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study | ||
| NCT02987829 | Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients | ||
| NCT00277654 | Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT04371380 | Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants | ||
| NCT01837862 | A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | ||
| NCT03823924 | Changes in Body Composition Under Ustekinumab in PsA | ||
| NCT02429791 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1) | ||
| NCT00177164 | Risperdal Consta for Bipolar Disorder | ||
| NCT01641367 | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure | ||
| NCT06083922 | A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) | ||
| NCT02172872 | "InDACtion" vs "3+7" Induction in AML | ||
| NCT02756247 | A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma | ||
| NCT03063203 | Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia | ||
| NCT02800928 | Does CERC-501 Attenuate Stress-precipitated Smoking Lapse? | ||
| NCT06396533 | Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) | ||
| NCT00140426 | A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa | ||
| NCT03522259 | Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery | ||
| NCT03290950 | A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT03696160 | The Late Presenter Treatment Optimisation Study | ||
| NCT04162366 | A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease. | ||
| NCT00215241 | Risperidone Augmentation for PTSD | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT03993847 | CLassification of Axial SpondyloarthritiS Inception Cohort | ||
| NCT05601973 | Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI | ||
| NCT03939182 | Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma |
